[Application of bisalkaloid derivatives of dicarboxylic acids based on lupinine, anabasine and cytisine as cholinesterase inhibitors of various origin].
E V
EV
Rozengart
N E
NE
Basova
D000470:Alkaloids / Q000737:chemistry*; D000691:Anabasine / Q000031:analogs & derivatives* / Q000737:chemistry*; D000818:Animals; D001392:Azocines / Q000737:chemistry*; D002091:Butyrylcholinesterase / Q000737:chemistry; D002800:Cholinesterase Inhibitors / Q000737:chemistry*; D002802:Cholinesterases / Q000737:chemistry; D049832:Decapodiformes; D003998:Dicarboxylic Acids / Q000737:chemistry*; D004912:Erythrocytes / Q000201:enzymology; D017952:Ganglia, Invertebrate / Q000201:enzymology; D005977:Glutarates / Q000737:chemistry; D006736:Horses; D006801:Humans; D007700:Kinetics; D011807:Quinolizines / Q000737:chemistry*; D013034:Sparteine / Q000031:analogs & derivatives* / Q000737:chemistry*; D013045:Species Specificity; D013329:Structure-Activity Relationship; D000093843:Quinolizidine Alkaloids
D000470:Alkaloids; D000691:Anabasine; D001392:Azocines; D002091:Butyrylcholinesterase; D002800:Cholinesterase Inhibitors; D002802:Cholinesterases; D003998:Dicarboxylic Acids; D005977:Glutarates; D011807:Quinolizines; D013034:Sparteine; C015971:lupinine; D000093843:Quinolizidine Alkaloids; C004712:cytisine; C035736:glutaric acid